Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
70
AVDL Quote, Financials, Valuation and Earnings
Last price:
$21.59
Seasonality move
:
17.56%
Day range:
$21.52 - $21.67
52-week range:
$6.38 - $23.57
Dividend yield:
0%
P/E ratio:
299.90x
P/S ratio:
8.54x
P/B ratio:
21.47x
Volume:
912.3K
Avg. volume:
2.4M
1-year change:
110.95%
Market cap:
$2.1B
Revenue:
$169.1M
EPS (TTM):
-$0.01
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
AVDL
Avadel Pharmaceuticals Plc
|
$73.6M | $0.05 | 59.29% | -76.67% | $20.94 |
|
ALKS
Alkermes Plc
|
$356.2M | $0.39 | -11.96% | -54.31% | $43.88 |
|
AMRN
Amarin Corp. Plc
|
$43.1M | -- | -18% | -100% | $12.00 |
|
JAZZ
Jazz Pharmaceuticals Plc
|
$1.1B | $5.85 | 6.17% | 106.38% | $213.00 |
|
MDT
Medtronic Plc
|
$8.9B | $1.31 | 7.23% | 32.69% | $110.97 |
|
STE
STERIS Plc (Ireland)
|
$1.4B | $2.35 | 8.05% | 44.25% | $281.63 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
AVDL
Avadel Pharmaceuticals Plc
|
$21.59 | $20.94 | $2.1B | 299.90x | $0.00 | 0% | 8.54x |
|
ALKS
Alkermes Plc
|
$28.50 | $43.88 | $4.7B | 14.10x | $0.00 | 0% | 3.15x |
|
AMRN
Amarin Corp. Plc
|
$13.75 | $12.00 | $285.9M | -- | $0.00 | 0% | 7.17x |
|
JAZZ
Jazz Pharmaceuticals Plc
|
$170.80 | $213.00 | $10.4B | 15.09x | $0.00 | 0% | 2.51x |
|
MDT
Medtronic Plc
|
$97.27 | $110.97 | $124.7B | 26.28x | $0.71 | 2.9% | 3.60x |
|
STE
STERIS Plc (Ireland)
|
$255.68 | $281.63 | $25.1B | 36.39x | $0.63 | 0.94% | 4.43x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
AVDL
Avadel Pharmaceuticals Plc
|
27.56% | 0.282 | 2.52% | 2.14x |
|
ALKS
Alkermes Plc
|
3.97% | 0.557 | 1.45% | 3.09x |
|
AMRN
Amarin Corp. Plc
|
1.45% | 2.841 | 1.98% | 2.35x |
|
JAZZ
Jazz Pharmaceuticals Plc
|
57.83% | 0.150 | 67.81% | 1.24x |
|
MDT
Medtronic Plc
|
37.43% | 0.567 | 24.98% | 1.50x |
|
STE
STERIS Plc (Ireland)
|
22.7% | 0.308 | 8.48% | 1.46x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
AVDL
Avadel Pharmaceuticals Plc
|
$80.5M | $1.9M | -0.23% | -0.34% | 2.5% | $23.2M |
|
ALKS
Alkermes Plc
|
$341.2M | $89.1M | 20.4% | 22.16% | 22.6% | $84.4M |
|
AMRN
Amarin Corp. Plc
|
$21.2M | -$1.7M | -17.51% | -17.79% | -3.42% | -$12.8M |
|
JAZZ
Jazz Pharmaceuticals Plc
|
$828.9M | $161.5M | -3.78% | -9.16% | 14.34% | $429.4M |
|
MDT
Medtronic Plc
|
$5.4B | $1.7B | 6.21% | 9.84% | 19.31% | $457M |
|
STE
STERIS Plc (Ireland)
|
$644.9M | $268.9M | 7.73% | 10.26% | 18.41% | $201.3M |
Avadel Pharmaceuticals Plc vs. Competitors
-
Which has Higher Returns AVDL or ALKS?
Alkermes Plc has a net margin of 0.03% compared to Avadel Pharmaceuticals Plc's net margin of 21%. Avadel Pharmaceuticals Plc's return on equity of -0.34% beat Alkermes Plc's return on equity of 22.16%.
Company Gross Margin Earnings Per Share Invested Capital AVDLAvadel Pharmaceuticals Plc90.66% $0.00 $135.6M ALKSAlkermes Plc86.56% $0.49 $1.8B -
What do Analysts Say About AVDL or ALKS?
Avadel Pharmaceuticals Plc has a consensus price target of $20.94, signalling downside risk potential of -2.8%. On the other hand Alkermes Plc has an analysts' consensus of $43.88 which suggests that it could grow by 54%. Given that Alkermes Plc has higher upside potential than Avadel Pharmaceuticals Plc, analysts believe Alkermes Plc is more attractive than Avadel Pharmaceuticals Plc.
Company Buy Ratings Hold Ratings Sell Ratings AVDLAvadel Pharmaceuticals Plc0 10 0 ALKSAlkermes Plc11 3 0 -
Is AVDL or ALKS More Risky?
Avadel Pharmaceuticals Plc has a beta of 1.262, which suggesting that the stock is 26.242% more volatile than S&P 500. In comparison Alkermes Plc has a beta of 0.450, suggesting its less volatile than the S&P 500 by 55.029%.
-
Which is a Better Dividend Stock AVDL or ALKS?
Avadel Pharmaceuticals Plc has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Alkermes Plc offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Avadel Pharmaceuticals Plc pays -- of its earnings as a dividend. Alkermes Plc pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AVDL or ALKS?
Avadel Pharmaceuticals Plc quarterly revenues are $77.5M, which are smaller than Alkermes Plc quarterly revenues of $394.2M. Avadel Pharmaceuticals Plc's net income of $20K is lower than Alkermes Plc's net income of $82.8M. Notably, Avadel Pharmaceuticals Plc's price-to-earnings ratio is 299.90x while Alkermes Plc's PE ratio is 14.10x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Avadel Pharmaceuticals Plc is 8.54x versus 3.15x for Alkermes Plc. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AVDLAvadel Pharmaceuticals Plc8.54x 299.90x $77.5M $20K ALKSAlkermes Plc3.15x 14.10x $394.2M $82.8M
-
Which has Higher Returns AVDL or AMRN?
Amarin Corp. Plc has a net margin of 0.03% compared to Avadel Pharmaceuticals Plc's net margin of -15.58%. Avadel Pharmaceuticals Plc's return on equity of -0.34% beat Amarin Corp. Plc's return on equity of -17.79%.
Company Gross Margin Earnings Per Share Invested Capital AVDLAvadel Pharmaceuticals Plc90.66% $0.00 $135.6M AMRNAmarin Corp. Plc42.97% -$0.37 $465.6M -
What do Analysts Say About AVDL or AMRN?
Avadel Pharmaceuticals Plc has a consensus price target of $20.94, signalling downside risk potential of -2.8%. On the other hand Amarin Corp. Plc has an analysts' consensus of $12.00 which suggests that it could fall by -12.15%. Given that Amarin Corp. Plc has more downside risk than Avadel Pharmaceuticals Plc, analysts believe Avadel Pharmaceuticals Plc is more attractive than Amarin Corp. Plc.
Company Buy Ratings Hold Ratings Sell Ratings AVDLAvadel Pharmaceuticals Plc0 10 0 AMRNAmarin Corp. Plc0 1 1 -
Is AVDL or AMRN More Risky?
Avadel Pharmaceuticals Plc has a beta of 1.262, which suggesting that the stock is 26.242% more volatile than S&P 500. In comparison Amarin Corp. Plc has a beta of 0.708, suggesting its less volatile than the S&P 500 by 29.246%.
-
Which is a Better Dividend Stock AVDL or AMRN?
Avadel Pharmaceuticals Plc has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Amarin Corp. Plc offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Avadel Pharmaceuticals Plc pays -- of its earnings as a dividend. Amarin Corp. Plc pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AVDL or AMRN?
Avadel Pharmaceuticals Plc quarterly revenues are $77.5M, which are larger than Amarin Corp. Plc quarterly revenues of $49.4M. Avadel Pharmaceuticals Plc's net income of $20K is higher than Amarin Corp. Plc's net income of -$7.7M. Notably, Avadel Pharmaceuticals Plc's price-to-earnings ratio is 299.90x while Amarin Corp. Plc's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Avadel Pharmaceuticals Plc is 8.54x versus 7.17x for Amarin Corp. Plc. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AVDLAvadel Pharmaceuticals Plc8.54x 299.90x $77.5M $20K AMRNAmarin Corp. Plc7.17x -- $49.4M -$7.7M
-
Which has Higher Returns AVDL or JAZZ?
Jazz Pharmaceuticals Plc has a net margin of 0.03% compared to Avadel Pharmaceuticals Plc's net margin of 22.33%. Avadel Pharmaceuticals Plc's return on equity of -0.34% beat Jazz Pharmaceuticals Plc's return on equity of -9.16%.
Company Gross Margin Earnings Per Share Invested Capital AVDLAvadel Pharmaceuticals Plc90.66% $0.00 $135.6M JAZZJazz Pharmaceuticals Plc73.6% $4.08 $9.4B -
What do Analysts Say About AVDL or JAZZ?
Avadel Pharmaceuticals Plc has a consensus price target of $20.94, signalling downside risk potential of -2.8%. On the other hand Jazz Pharmaceuticals Plc has an analysts' consensus of $213.00 which suggests that it could grow by 24.71%. Given that Jazz Pharmaceuticals Plc has higher upside potential than Avadel Pharmaceuticals Plc, analysts believe Jazz Pharmaceuticals Plc is more attractive than Avadel Pharmaceuticals Plc.
Company Buy Ratings Hold Ratings Sell Ratings AVDLAvadel Pharmaceuticals Plc0 10 0 JAZZJazz Pharmaceuticals Plc10 2 0 -
Is AVDL or JAZZ More Risky?
Avadel Pharmaceuticals Plc has a beta of 1.262, which suggesting that the stock is 26.242% more volatile than S&P 500. In comparison Jazz Pharmaceuticals Plc has a beta of 0.305, suggesting its less volatile than the S&P 500 by 69.522%.
-
Which is a Better Dividend Stock AVDL or JAZZ?
Avadel Pharmaceuticals Plc has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Jazz Pharmaceuticals Plc offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Avadel Pharmaceuticals Plc pays -- of its earnings as a dividend. Jazz Pharmaceuticals Plc pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AVDL or JAZZ?
Avadel Pharmaceuticals Plc quarterly revenues are $77.5M, which are smaller than Jazz Pharmaceuticals Plc quarterly revenues of $1.1B. Avadel Pharmaceuticals Plc's net income of $20K is lower than Jazz Pharmaceuticals Plc's net income of $251.4M. Notably, Avadel Pharmaceuticals Plc's price-to-earnings ratio is 299.90x while Jazz Pharmaceuticals Plc's PE ratio is 15.09x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Avadel Pharmaceuticals Plc is 8.54x versus 2.51x for Jazz Pharmaceuticals Plc. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AVDLAvadel Pharmaceuticals Plc8.54x 299.90x $77.5M $20K JAZZJazz Pharmaceuticals Plc2.51x 15.09x $1.1B $251.4M
-
Which has Higher Returns AVDL or MDT?
Medtronic Plc has a net margin of 0.03% compared to Avadel Pharmaceuticals Plc's net margin of 15.42%. Avadel Pharmaceuticals Plc's return on equity of -0.34% beat Medtronic Plc's return on equity of 9.84%.
Company Gross Margin Earnings Per Share Invested Capital AVDLAvadel Pharmaceuticals Plc90.66% $0.00 $135.6M MDTMedtronic Plc60.45% $1.07 $78B -
What do Analysts Say About AVDL or MDT?
Avadel Pharmaceuticals Plc has a consensus price target of $20.94, signalling downside risk potential of -2.8%. On the other hand Medtronic Plc has an analysts' consensus of $110.97 which suggests that it could grow by 14.08%. Given that Medtronic Plc has higher upside potential than Avadel Pharmaceuticals Plc, analysts believe Medtronic Plc is more attractive than Avadel Pharmaceuticals Plc.
Company Buy Ratings Hold Ratings Sell Ratings AVDLAvadel Pharmaceuticals Plc0 10 0 MDTMedtronic Plc12 15 0 -
Is AVDL or MDT More Risky?
Avadel Pharmaceuticals Plc has a beta of 1.262, which suggesting that the stock is 26.242% more volatile than S&P 500. In comparison Medtronic Plc has a beta of 0.710, suggesting its less volatile than the S&P 500 by 28.968%.
-
Which is a Better Dividend Stock AVDL or MDT?
Avadel Pharmaceuticals Plc has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Medtronic Plc offers a yield of 2.9% to investors and pays a quarterly dividend of $0.71 per share. Avadel Pharmaceuticals Plc pays -- of its earnings as a dividend. Medtronic Plc pays out 77.47% of its earnings as a dividend. Medtronic Plc's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios AVDL or MDT?
Avadel Pharmaceuticals Plc quarterly revenues are $77.5M, which are smaller than Medtronic Plc quarterly revenues of $9B. Avadel Pharmaceuticals Plc's net income of $20K is lower than Medtronic Plc's net income of $1.4B. Notably, Avadel Pharmaceuticals Plc's price-to-earnings ratio is 299.90x while Medtronic Plc's PE ratio is 26.28x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Avadel Pharmaceuticals Plc is 8.54x versus 3.60x for Medtronic Plc. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AVDLAvadel Pharmaceuticals Plc8.54x 299.90x $77.5M $20K MDTMedtronic Plc3.60x 26.28x $9B $1.4B
-
Which has Higher Returns AVDL or STE?
STERIS Plc (Ireland) has a net margin of 0.03% compared to Avadel Pharmaceuticals Plc's net margin of 13.18%. Avadel Pharmaceuticals Plc's return on equity of -0.34% beat STERIS Plc (Ireland)'s return on equity of 10.26%.
Company Gross Margin Earnings Per Share Invested Capital AVDLAvadel Pharmaceuticals Plc90.66% $0.00 $135.6M STESTERIS Plc (Ireland)44.16% $1.94 $9.1B -
What do Analysts Say About AVDL or STE?
Avadel Pharmaceuticals Plc has a consensus price target of $20.94, signalling downside risk potential of -2.8%. On the other hand STERIS Plc (Ireland) has an analysts' consensus of $281.63 which suggests that it could grow by 10.15%. Given that STERIS Plc (Ireland) has higher upside potential than Avadel Pharmaceuticals Plc, analysts believe STERIS Plc (Ireland) is more attractive than Avadel Pharmaceuticals Plc.
Company Buy Ratings Hold Ratings Sell Ratings AVDLAvadel Pharmaceuticals Plc0 10 0 STESTERIS Plc (Ireland)3 2 0 -
Is AVDL or STE More Risky?
Avadel Pharmaceuticals Plc has a beta of 1.262, which suggesting that the stock is 26.242% more volatile than S&P 500. In comparison STERIS Plc (Ireland) has a beta of 1.011, suggesting its more volatile than the S&P 500 by 1.146%.
-
Which is a Better Dividend Stock AVDL or STE?
Avadel Pharmaceuticals Plc has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. STERIS Plc (Ireland) offers a yield of 0.94% to investors and pays a quarterly dividend of $0.63 per share. Avadel Pharmaceuticals Plc pays -- of its earnings as a dividend. STERIS Plc (Ireland) pays out 35.14% of its earnings as a dividend. STERIS Plc (Ireland)'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios AVDL or STE?
Avadel Pharmaceuticals Plc quarterly revenues are $77.5M, which are smaller than STERIS Plc (Ireland) quarterly revenues of $1.5B. Avadel Pharmaceuticals Plc's net income of $20K is lower than STERIS Plc (Ireland)'s net income of $192.5M. Notably, Avadel Pharmaceuticals Plc's price-to-earnings ratio is 299.90x while STERIS Plc (Ireland)'s PE ratio is 36.39x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Avadel Pharmaceuticals Plc is 8.54x versus 4.43x for STERIS Plc (Ireland). Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AVDLAvadel Pharmaceuticals Plc8.54x 299.90x $77.5M $20K STESTERIS Plc (Ireland)4.43x 36.39x $1.5B $192.5M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
